Surmodics Net Profit Margin 2010-2024 | SRDX
Surmodics net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Surmodics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.13B | $-0.02B | -12.00% |
| 2024-09-30 | $0.13B | $-0.01B | -9.52% |
| 2024-06-30 | $0.12B | $0.00B | -1.65% |
| 2024-03-31 | $0.14B | $0.01B | 9.09% |
| 2023-12-31 | $0.14B | $0.01B | 3.62% |
| 2023-09-30 | $0.13B | $0.00B | -1.52% |
| 2023-06-30 | $0.13B | $-0.02B | -18.46% |
| 2023-03-31 | $0.10B | $-0.04B | -35.92% |
| 2022-12-31 | $0.10B | $-0.03B | -32.35% |
| 2022-09-30 | $0.10B | $-0.03B | -28.00% |
| 2022-06-30 | $0.10B | $-0.01B | -13.27% |
| 2022-03-31 | $0.10B | $-0.01B | -10.31% |
| 2021-12-31 | $0.11B | $0.00B | 1.89% |
| 2021-09-30 | $0.11B | $0.01B | 4.76% |
| 2021-06-30 | $0.10B | $0.00B | 1.92% |
| 2021-03-31 | $0.11B | $0.01B | 6.54% |
| 2020-12-31 | $0.10B | 0 | 0.00% |
| 2020-09-30 | $0.10B | 0 | 0.00% |
| 2020-06-30 | $0.10B | $0.01B | 6.73% |
| 2020-03-31 | $0.10B | $0.01B | 5.94% |
| 2019-12-31 | $0.10B | $0.01B | 5.94% |
| 2019-09-30 | $0.10B | $0.01B | 7.00% |
| 2019-06-30 | $0.09B | $0.00B | 1.09% |
| 2019-03-31 | $0.09B | $0.00B | -3.33% |
| 2018-12-31 | $0.09B | $0.00B | -2.33% |
| 2018-09-30 | $0.08B | $-0.01B | -6.17% |
| 2018-06-30 | $0.08B | $0.00B | -3.85% |
| 2018-03-31 | $0.07B | $0.00B | 1.35% |
| 2017-12-31 | $0.07B | 0 | 0.00% |
| 2017-09-30 | $0.07B | $0.00B | 5.41% |
| 2017-06-30 | $0.07B | $0.01B | 9.72% |
| 2017-03-31 | $0.07B | $0.01B | 13.51% |
| 2016-12-31 | $0.07B | $0.01B | 13.70% |
| 2016-09-30 | $0.07B | $0.01B | 15.28% |
| 2016-06-30 | $0.07B | $0.01B | 12.68% |
| 2016-03-31 | $0.07B | $0.01B | 13.43% |
| 2015-12-31 | $0.06B | $0.01B | 17.19% |
| 2015-09-30 | $0.06B | $0.01B | 19.67% |
| 2015-06-30 | $0.06B | $0.01B | 22.03% |
| 2015-03-31 | $0.06B | $0.01B | 22.41% |
| 2014-12-31 | $0.06B | $0.01B | 20.69% |
| 2014-09-30 | $0.06B | $0.01B | 20.69% |
| 2014-06-30 | $0.06B | $0.01B | 24.56% |
| 2014-03-31 | $0.06B | $0.01B | 23.21% |
| 2013-12-31 | $0.06B | $0.02B | 26.79% |
| 2013-09-30 | $0.06B | $0.02B | 26.79% |
| 2013-06-30 | $0.06B | $0.01B | 25.00% |
| 2013-03-31 | $0.06B | $0.01B | 25.00% |
| 2012-12-31 | $0.05B | $0.01B | 22.22% |
| 2012-09-30 | $0.05B | $0.01B | 21.15% |
| 2012-06-30 | $0.05B | $-0.01B | -21.15% |
| 2012-03-31 | $0.05B | $-0.01B | -19.61% |
| 2011-12-31 | $0.05B | $-0.01B | -19.23% |
| 2011-09-30 | $0.05B | $-0.02B | -35.85% |
| 2011-06-30 | $0.06B | $-0.02B | -40.00% |
| 2011-03-31 | $0.06B | $-0.03B | -44.26% |
| 2010-12-31 | $0.07B | $-0.03B | -43.94% |
| 2010-09-30 | $0.07B | $-0.02B | -30.00% |
| 2010-06-30 | $0.07B | $0.00B | 5.48% |
| 2010-03-31 | $0.07B | $0.01B | 12.50% |
| 2009-12-31 | $0.08B | $0.01B | 17.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.388B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.051B | 28.02 |
| Boston Scientific (BSX) | United States | $155.046B | 38.81 |
| Stryker (SYK) | United States | $146.591B | 30.65 |
| EssilorLuxottica (ESLOY) | France | $128.427B | 0.00 |
| Medtronic (MDT) | Ireland | $106.656B | 15.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.530B | 27.59 |
| ResMed (RMD) | United States | $35.880B | 26.95 |
| GE HealthCare Technologies (GEHC) | United States | $31.512B | 14.96 |
| Agilent Technologies (A) | United States | $30.654B | 20.25 |
| Terumo (TRUMY) | Japan | $28.279B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.455B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.623B | 11.96 |
| Insulet (PODD) | United States | $18.597B | 79.37 |
| Baxter (BAX) | United States | $15.765B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.910B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.514B | 22.02 |
| Lantheus Holdings (LNTH) | United States | $5.512B | 14.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 19.25 |
| Perrigo (PRGO) | Ireland | $3.604B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.310B | 28.20 |
| Haemonetics (HAE) | United States | $3.228B | 15.19 |
| Envista Holdings (NVST) | United States | $2.854B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.010B | 16.65 |
| LeMaitre Vascular (LMAT) | United States | $1.844B | 41.21 |
| QuidelOrtho (QDEL) | United States | $1.744B | 12.02 |
| AtriCure (ATRC) | United States | $1.500B | 0.00 |
| Neogen (NEOG) | United States | $1.287B | 16.47 |
| Green Thumb Industries (GTBIF) | United States | $1.274B | 28.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.121B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.111B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.014B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.785B | 10.05 |
| Evolus (EOLS) | United States | $0.758B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 5.11 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.551B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.435B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.411B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 14.59 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.315B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 24.23 |
| Verano Holdings (VRNOF) | United States | $0.287B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 45.90 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 14.83 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.183B | 5.14 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.39 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.086B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.24 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |